Influence of interleukin-1 receptor antagonist gene polymorphism on disease

Clinical Infectious Diseases

Volumn 34, Issue 2, 2002, Pages 204-209

  Witkin, S S ^a   Gerber, S ^a   Ledger, W J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLELE; CORONARY ARTERY DISEASE; CROHN DISEASE; CYTOMEGALOVIRUS; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; INFLAMMATION; LUPUS ERYTHEMATOSUS; MALIGNANT TRANSFORMATION; MYCOPLASMA; OSTEOPOROSIS; PHENOTYPE; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; ULCERATIVE COLITIS; VULVAR VESTIBULITIS;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS;

EID: 0037079943     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/338261     Document Type: Review

References (55)

1. Biology of interleukin 1
2. The human interleukin-1 receptor antagonist (IL1RN) gene maps to chromosome 2q14-q21, in the region of the IL-1α and IL-1β loci
3. Inhibition of interleukin 1 binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody
4. Production of interleukin-1 receptor antagonist during experimental endotoxaemia
5. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice
6. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-base pair tandem repeat
7. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies
8. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease and in control individuals
9. Cytokine production by normal human monocytes: Inter-subject variation and relationship to an IL-1 receptor antagonist gene polymorphism
10. Allelic polymorphism in IL-1β and IL-1 receptor antagonist genes in inflammatory bowel disease
11. Presence of the IL-1RA allele 2 (IL-1RN*2) is associated with enhanced IL-1 production in vitro
12. Influence of polymorphism in the genes for the interleukin-1 receptor antagonist and IL-1β on tuberculosis
13. Imbalance of the interleukin 1 system in colonic mucosa-association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2
14. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis
15. IL-1 receptor antagonist plasma levels are coordinately regulated by both IL-1Ra and IL-1 genes
16. Circulating cytokine levels in osteoporotic and normal women
17. Gender differences in IL-1α, IL-1β, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion
18. Increased interleukin-1 and interleukin-1 receptor antagonist levels in cervical mucus in the ovulatory phase in comparison with the follicular phase
19. Interleukin-1 receptor antagonist: Role in biology
20. Cytokine antagonists in aged subjects and their relation with cellular immunity
21. Influence of fetal gender on the concentration of interleukin-1 receptor antagonist in amniotic fluid and in newborn urine
22. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys
23. The natural interleukin-1 receptor antagonist prevents interleukin-1 induced preterm delivery in mice
24. The natural interleukin-1 receptor antagonist in term and preterm parturition
25. Induction of interleukin-1 receptor antagonist in rhesus monkeys after intraamniotic infection with group B streptococci or interleukin-1 infusion
26. Polymorphism in the interleukin-1 gene complex and preterm labor in Hispanic women
27. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium
28. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development
29. Polymorphisms within the interleukin-1β gene cluster and preeclampsia
30. Severity, of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene
31. Association between interleukin-1 receptor antagonist gene polymorphism and early and late-onset psoriasis
32. Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus
33. Synergetic effect between interleukin-1 receptor antagonist allele (ILRN*2) and MHC class II (DR17,DQ2) in determining susceptibility, to systemic lupus erythematosus
34. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis
35. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis
36. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist
37. Significant differences in the interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms in a Hungarian population with inflammatory bowel disease
38. Relationship between Ureaplasma urealyticum vaginal colonization and polymorphism in the interleukin-1 receptor antagonist gene
39. Resistance to human cytomegalovirus infection may be influenced by genetic polymorphisms of the tumor necrosis factor-alpha and interleukin-1 receptor antagonist genes
40. Polymorphism of the IL-1 gene complex and Epstein-Barr virus seronegative and seropositive adult blood donors
41. Interleukin-1 receptor antagonist gene polymorphism and circulating levels of HIV-1 RNA in Brazilian women
42. Elevation of serum interleukin-1 receptor antagonist levels in women with gynecological cancers
43. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats
44. Immunologic aspects of osteoporosis
45. Estrogen's protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells
46. Cytokines and bone loss in a 5 year longitudinal study-hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1 receptor antagonist: The Danish Osteoporosis Prevention Study
47. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine
48. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1 receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene
49. Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women
50. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease
51. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting
52. Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease
53. Biologic basis for interleukin-1 in disease
54. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
55. Treatment of rheumatoid arthritis with IL-1 inhibitors